Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons. by Traylor, Dennis & Breese, George R.
During the past few years, understanding of
the role and mechanisms of the peripheral symp
athetic nervous system has been advanced by the
development of techniques of sympathectomy
and through the use of an array of pharmaco
logic agents. Nevertheless, central noradrenergic
mechanisms have been more difficult to assess.
The diffuse nature of the noradrenergic system
(Carlsson et al., 1962) has made discrete lesion
ing of norepinephrine cells in brain virtually im
possible. Furthermore, pharmacologic agents
used to study central mechanisms have had the
disadvantage of altering not only the catechol
amine systems in the central nervous system but
alsoin the periphery.A pharmacologicagent
which could be introduced directly into the cen
tral nervous system and which would destroy
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ABSTRACT
BREESE, Gsoaoz R. @tmwT. DENNIS TRAYLOR: Effect of 6-hydroxydopamine on brain norepi
nephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J.
Pharmacol. Exp. Ther. 174: 413-420, 1970. After the intracisternal administration of 6-
hydroxydopamine, brain levels of norepinephrine were reduced significantly with or without
pargyline pretreatment. Depletion of dopamine in the central nervous system was found to
be enhanced markedly by pargyline adminintration at higher dose levels of 6-hydroxydopa
mine. Brain serotonin concentrations were not altered. The effects of 6-hydroxydopamine
were long-lasting with the depletion of brain amines persisting at 78 days. After norepineph
rine-H intracisternally to animals treated with 6-hydroxydopamine, labeled norepinephrine
uptake was diminished with a corresponding reduction of deaminated catechols and a marked
increased in methylated amines. Tyrosine hydroxylase activity was found to be reduced in
brainstem, caudate nucleus and whole brain in 6-hydroxydopamine-treated animals. Conver
sion of tyrosine-H' to labeled norepinephrine and dopaniine was also markedly diminiahed.
The results support the view that 6-hydroxydopamine produces a â€œ¿centralsympathectomyâ€•
when introduced into cerebrospinal fluid.
the central noradrenergic system without alter
ing the peripheral system would offer obvious
advantages. Recent observations suggest that 6-
hydroxydopamine may prove to be such an
agent (Tranzer and Thoenen, 1968; Uretsky and
Iversen, 1969).
The observation by Porter et at. (1963) and
Laverty et at. (1965) that 6-hydroxydopamine
induced a long-lasting depletion of norepineph
rine in peripheral organs with sympathetic in
nervation led to the hypothesis that 6-hydroxy
dopamine destroyed norepinephrine binding sites
(Porter et at., 1963). Recently, Tranzer and
Thoenen (1968) have confirmed and extended
these observations showing that two weeks after
treatment with 6-hydroxydopamine virtually all
adrenergic fibers were absent from sympatheti
cally innervated tissues. These reports of pe
ripheral chemical sympathectomy by 6-hydroxy
dopamine (Thoenen and Tranzer, 1968; Tranzer
and Thoenen, 1968) led to investigation of the
possibility that 6-hydroxydopamine might also
produce selective destruction of brain catech
amine neurons when introduced into the
nervous system (Uretsky and Iversen, 1
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the alumina was transferred to a chromatographic
column and washed with 10 ml of 0.4 N sodium
acetate solution (pH 8.6) and with 20 ml of glass
distilled water. The catecholamines were eluted
from the alumina wtih 7 ml of 02 N acetic acid.
Endogenous norepinephrine in the acetic acid
eluate was assayed according to the method of
Haggendal (1963) except that mercaptoethanol was
substituted for British anti-lewisite. Dopamine was
assayed according to the method of Anton and
Sayre (1964). Values for endogenous amines were
uncorrected for recovery which averaged 89% for
norepinephrine and 84% for dopamine. Brain
serotonin was isolated from an aliquot of the
supernatant by the method of Bogdanski et at.
(1956) and measured by the fluorescent method of
Snyder et at. (1965).
Some animals were given norepinephrine-H'
(5 @c,7.1 c/mmol) intracisternally in a volume of
25 @l.After the procedure outlined above for
killing and homogenization, labeled norepinephrine
and its metabolites were isolated with the method
of Schanberg et at. (1967). When tyrosine-H' (34.7
c/mmol) was injected either intracisternally (15
@c)or i.v. (40 sc), the animals were sacrificed one
hour later; radioactive norepinephrine and dopa
mine formed from tyrosine-il' were isolated ac
cording to the method of Sedvall et at. (1968).
Less than 0.5% dopamine was noted in the nor
epinephrine fraction and vice versa. Radioactive
amine values were uncorrected for recovery which
was 80% for norepinephrine and 70% for dopa
mine. AU radioactivity was measured by scintilla
tion spectrometry; an internal standard of tolu
ene-H'wasusedtocorrectforcountingefficiency.
Dissection of brain parts was performed on a
moistened filter paper placed on a chilled glass
plate. The term â€œ¿brainstemâ€•as used in this manu
script refers to the area of brain caudal to a cut
made behind the superior colliculi after removal
of the cerebellar cortices. The term â€œ¿caudateâ€•r
fers to that area of brain which lies adjacent to the
lateral ventricle and is bounded by the radiation of
the corpus callosum. Access to the caudate mass,
which contained portions of the globus palhidus,
was obtained through the lateral ventricle after
hemisection of the whole brain. After removal of
the caudate, the remainder of the brain tissue was
assayed and is referred to as â€œ¿restof brain.â€•
Tyrosine hydroxylase was isolated from whole
brain and brain parts according to the method of
Musacchio et at. (1969) except that the enzyme
was precipitatedfrom a 1:1mixtureof sample
and ammonium sulfate solution. Enzyme activity
was determined by measuring the formation of
tritiated water from 3 ,5-ditritiotyrosine in a mod
ified procedure of Nagatsu et al. (1964). The in
cubation mixture for whole brain, rest of brain and
Bloom et at., 1969 ; Anagnoste et at., 1969;
Traylor and Breese, 1970) . Ungerstedt (1968)
reported that 6-hydroxydopamine produced de
generation of central catecholamine neurons
when injected into a localized area of brain.
Utilizing electron micrographic examination of
areas rich in adrenergic neurons, Bloom and as
sociates (1969) demonstrated that 6-hydroxy
dopamine administered into cerebrospinal fluid
caused degeneration of central noradrenergic fi
bers.
The present experiments were designed to in
vestigate the depletion of brain catecholamines
after intracisternally administered 6-hydroxy
dopamine, to determine the effect of this pro
cedure on the retention and metabolism of in
tracisternally administered H3-norepinephrine
and to measure the effect of this derivative on
brain tyrosine hydroxylase. Experiments were
performed on animals with or without pargyline
pretreatment. Our data further support the
view that 6-hydroxydopamine can produce se
lective degeneration of central catecholamine
containing neurons.
METHODS. Male Sprague-Dawley rats (140-180
g) were given from 25 to 200 @igof 6-hydroxydopa
mine hydrobromide intracisternally as described
previously (Schanberg et al., 1968). The com
pound was dissolved in Elliott's â€œ¿Bâ€•solution (Bax
ter Laboratories, Inc., Morton Grove, Ill.) con
taining 1 mg/mi of ascorbic acid to prevent oxida
tion of the 6-hydroxydopamine; total volume ad
ministered was 25 @d.In an attempt to decrease
deamination of 6-hydroxydopamine (Breese et al.,
1969), some animals received 50 mg/kg of pargyline
i.p. 30 minutes before the 6-hydroxydopamine in
jection. A second dose of 6-hydroxydopamine (200
/Lg)was administered to a few animals seven days
after the first injection; pargyline was adminis
tered with the first but not with the second dose.
After the surgical procedure, each animal received
0.05 ml of benzathine penicillin G suspension i.m.
For the measurement of brain concentrations
of norepinephrine, dopamine and serotonin, ani
mals were killed by cervical fracture and decapi
tated at various times after injection. Brains were
removed, rinsed in cold water, homogenized in 10
ml of ice-cold 0.4 N perchioric acid, frozen and
analyzed within 24 hours. After thawing and cen
trifugation of the homogenate, an aliquot of the
@ supernatant was adjusted to pH 8.6 with
m hydroxide, and the catecholamines were
rbed onto alumina (Woelm, neutral) by the
method of Anton and Sayre (1962). After stirring,
- B.
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Fic. 3. Effect of pargyhine on brain depletion
of catecholamines (A and B) by 6-hydroxydopa
mine. Various doses of 6-hydroxydopamine were
administered intracisternally to animals with or
without pargyline pretreatment. Animals were
sacrificed 16 or 21 days later. Stippled area indi
cates control values Â±S.E.M. of 20 animals. Each
point indicates the mean of 6 to 12 animals; verti
cal bar indicates the S.E.M. @,P < .01.
enzyme preparation. For measurement of activity
in caudate, half quantities of each reactant were
used with the final volume measuring 0.5 ml. In
cubation was at 37Â°Cfor 30 minutes. The reac
tion was terminated by the addition of 025 ml of
6% trichloroacetic acid. The mixture was centri
fuged and the supernatant placed on a column of
Dowex-50 (NH4@) (3 by 0.8 cm). The effluent and
one wash were combined and mixed with 10 ml of
phosphor-Triton (1:1) and counted. Monoamine
oxidase activity was measured according to the
method of Wurtman and Axelrod (1964).
The 6-hydroxydopamine HBr was purchased
from Regis Chemical Company (Chicago, Ill.) and
used without further purification. Pargyline was
kindly supplied by Abbott Laboratories (North
Chicago, Ill.) H'-tyrosine (34.7 c/mmol), H'-nor
epinephrine (7.1 c/mmol) and Câ€•-tryptamine (5
mc/mmol) were purchased from New England
Nuclear Corporation (Boston, Mass.). All doses of
the compounds used in this study are expressed as
their free base.
RESULTS. Effect of 6-hydroxydopamine on
brain norepinephrine, dopamine and 5-hydroxy
trypt amine. After the intracisternal injection of
@1@
75
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brainstem consisted of tyrosine (100 m@imol),
2.9 X 10' cpm of ditritiotyrosine, 0.5 @molof 2-
amino-4-hydroxy-6,7 dimethyltetrahydropteridine
in 0.1 ml of 1 M mercaptoethanol and 0.5 ml of
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Fia. 1. Effect of 6-hydroxydopamine (6-OH
DA) on brain norepinephrine, 5-hydroxytrypta
mine and dopamine. Animals pretreated with
pargyline received 200 i@g of 6-hydroxydopamine
intracisternally and were killed 21 days hater. Each
bar is the mean of 8 to 16 animals. Vertical bars
indicate S.E.M. , P < .001.
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Fia. 2. Effect of 6-hydroxydopamine on brain
norepinephrine (A) and dopamine (B) at various
times after injection. Ammals pretreated with
pargyline received 200 pg of 6-hydroxydopamine
and were killed at various times after this injec
tion. Control values for norepinephrine and dopa
mine were 605 Â±122 and 1136 Â±58 mpg, respec
tively. Vertical bars indicate S.E.M. Each value
represents six to eight determinations.
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different from that in 6-hydroxydopamine
treated animals which did not receive pargyline.
Thus, pargyline pretreatment does not appear
to offer any advantage in the 6-hydroxydopa
mine-induced depletion of brain norepinephrine.
With or without pargyline, heart norepineph
rine was not affected by intracisternally admin
istered 6-hydroxydopamine.
In contrast to the pargyline effect on norepi
nephrine depletion by 6-hydroxydopamine, a
quite different depleting pattern was noted on
dopamine (fig. 3) . Without pargyline, 6-hy
droxydopamine caused a dose-dependent reduc
tion of dopamine from 25 to 100 @g.The lower
doses of 6-hydroxydopainine did not cause a
significant depletion of dopamine in either the
pargyline or nontreated animals. However, 6-
hydroxydopam.ine adminiRtered at the 100 pg
and 200 pg doses to pargyline-treated animals
had marked effects on brain dopamine, depleting
the amine 66 and 76%, respectively. Animals
which did not receive pargyline before intra
cisternally administered 6-hydroxydopamine had
their brain dopamine reduced approximately
40%.
Metabolism of intracisternally administered
H'-norepinephrine in 6-hydroxydopamine
treated rats. Two hours after the intracisternal
administration of H'-norepinephrine, labeled
norepinephrine in brain tissue was found to be
reduced by 76% (fig. 4). At the same time, H'
normetanephrme was increased 264% and de
aminated catechols were reduced by 83%. The
O-methylated deaminated products of labeled
norepinephrine were only slightly elevated in
6-hydroxydopamine-treated animals.
Formation of labeled norepinephrine and
dopamine from H'-tyrosine. After the admin
istration of radioactive tyrosine, labeled dopa
mine and norepinephrineare formed (Sedvall
et al., 1968). Whether the label tyrosine was
administered i.v. or intracisternally, animals
treated with 6-hydroxydopamine were found to
have reduced amounts of labeled dopamine as
well as norepinephrine when compared to con
trols (table 1). In an attempt to determine if
6-hydroxydopamine might be interfering with
the storage of amines but not synthesis, animals
given H'-tyrosine i.v. were pretreated with
pargyline in an attempt to spare catecholaminea
which might be synthesized. Nevertheless, re
sults by the two routes of administration were
â€”¿ @NTR0L
@ 6-OH-DA
25
Nors@nephÃ±flSDsomi@sdNormslenÃ˜iins0-Mslhylolsd
Fic. 4. Effect of 6-hydroxydopaznine (6-OH
DA) on the metabolism of intracisternally admin
istered norepinephrine-H'. Two doses of 6-hy
droxydopamine (200 pg) were administered: the
first was injected to pargyline-treated animals 21
days before sacrifice and the second dose was ad
ministered 7 days after the first dose. Animals were
sacrificed 2 hours after the intracisternal injection
of R'-norepinepbrine (5 pc). Results are expressed
as percentage of control Â±SE.M. Each value
represents the mean of at least 10 determinations.
Control mean norepinep@rine-H'= 1000 m@j
brain- normetanephnne-liâ€• = 136 mpc/brain@ -
deam@nated catechols = 3 mpc/brain; la()eled
O-methylated deaminated metabolites = 700 mpc/
brain.', P < .001;@ P < .05.
200 @gof 6-hydroxydopamine in animals pre
treated with pargyline, brain norepinephrine
and dopamine were reduced without effecting
brain serotonin (fig. 1). The depleting effect on
brain norepinephrine and dopamine of a single
200 @ginjection of 6-hydroxydopamine after
monoamine oxidase inhibition was noted as early
as 3 days and persisted for as long as 78 days
(flg.2).
Effect of pargytine pretreatment on the reduc-.
tion of brain catecholamines by 6-hydroxydopa
mine. The administration of 6-hydroxydopamine
intracisternally was found to lower whole brain
norepinephrine significantly at all doses admin
istered irrespective of the presence or absence of
pargyline pretreatment (fig. 3). However, at the
lowest dose of 6-hydroxydopamine the admin
istration of pargyline was found to inhibit sig
nificantly (P < .01) the depleting effect of 6-
hydroxydopamine upon brain norepinephrine.
The effect of 200 @igof 6-hydroxydopamine in
pargyline-treated animals was not significantly
TyrosineAdministrationTreatmentH'-TyrosineH'-NorepinephrineH'-DopamlneIntravenousb
IntracisternalSaline
6-Hydroxydopamine
Saline
6-Hydroxydopamine243,000
Â±13,000
266,000 Â± 16,000
168,000 Â±9,500
174,000 Â±17,000710
Â±70
130 Â±25c
940 Â±100
218Â±34'565
Â±40
140Â±25'
555 Â±51
192 Â± 13'
Brain ParttNorepinephrineDopainineTyrosine
HydroxylaseMonoamineOxidaseControl
6-OH-DAControl 6-OH-DAControl 6-OH.DAControl6-OH-DAWholeBrain
Brainstem
Caudate
Restof brainfngig/g
330Â±9.5 74Â±4Â°
(25) (25)
450Â±18 91Â±6Â°
(3) (3)
174Â±20 48Â±15'
(4) (4)
319 Â±18 79 Â±10'
(5) (5)mgig/g
304Â±13 55Â±4Â°
(25) (25)
5880Â±203 1093Â±33Â°
(9) (8)
296 Â±23 140 Â±12Â°
(5) (5)gqassoi/mg/kr
4.32Â±0.28 0.96Â±0.18Â°
(8) (8)
6.26Â±0.55 1.30Â±0.46Â°
(8) (8)
20.7Â±2.10 2.53Â±0.20Â°
(14) (10)
4.33 Â±0.24 0.88 Â±0.18Â°
(8) (8)mgissol/mg/hr
1.11Â±0.10 1.09Â±0.10
(8) (8)
1.48Â±0.12 1.41Â±0.15
(8) (8)
1.40*0.15 1.41Â±0.14
(8) (8)
1.14 Â±0.11 1.12 Â±0.10
(8) (8)
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TABLE 1
Effect of 8-hydroxydopamine on the 8ynthesis of H'-catecholaminesfrom H'-tyrosine'
â€˜¿Resultsexpressed as counts per minute per brain and are the mean Â±S.E.M. of 6 to 12 determina
tions. Rats received 40 pc of H'-tyrosine iv. or 15 pc intracisternally 21 days after the intracisternal
injection of 6-hydroxydopamine (200pg, 2 doses). Animals were sacrificed 1 hour after the labeled tyro
sine.
b Animals received pargyline (50 mg/kg) 30 minutes before the administration of H'-tyrosine.
â€˜¿P<.001.
comparable. After i.v. injection of H'-tyrosine,
tritium-labelednorepinephrineformed was re
duced 82% while H'-dopamine formed was re
duced 75%. The amount of radioactive tyrosine
found in brain was not significantly different
from its corresponding control.
Effect of 6-hydroxydopamine on brain tyro
sine hydroxylase and monoamine oxidase activ
ity. In animals treated with 6-hydroxydopamine
in combination with pargyline, whole brain ty
rosine hydroxylase activity in vitro was found
to be decreased by approximately 80% (table
2). This was in close agreement with the deple
tion of whole brain catecholamines (fig. 1; ta
ble 2). A comparable loss of tyrosine hydrox
ylase activity and norepinephrine depletion was
also observed in brainstem. Tyrosine hydrox
ylase activity in the caudate, normally an active
region (McGeer et al., 1967), was markedly
reduced in 6-hydroxydopamine-treated rats.
Dopamine concentration in the caudate of ani
malssimilarlytreatedwas reducedby some81%
(table2).Tyrosinehydroxylaseactivityinbrain
portions remaining after removal of the caudate
was approximately 20% of control with cate
cholamine content being altered proportionally.
Brain monoamine oxidase showed no decrease
in whole brain or in brain parts examined (ta
ble 2).
DIscussIoN. The reports (Tranzer and
TABLE 2
Effect of 6-hydroxydopamine (8-OH-DA) on brain catecholaminee and tyros-ine hydrosylase activity'
â€˜¿Eachvalue represents the mean Â±8.E.M.; numbers in parentheses indicate the number of animals per group. Brain dissection.
described in MZTEODS.
b Animals in which whole brain and brainstem were assayed were given 2 doses of 6-hydroxydopamine (200 gig) as described In
Mrrnone. Animals in which the caudate and rest of brain were assayed received 200 pg of 6-hydroxydopamine with pargyline. All
animals were sacrificed 14 days after the Initial treatment.
â€˜¿P< .001.
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Thoenen, 1968; Malmfors and Sachs, 1968) that
6-hydroxydopamine caused a chemical sympa
thectomy peripherally prompted several labora
tories to investigate whether this compound
would display the same neurotoxicity toward
central catecholamine neurons (Uretsky and
Iversen, 1969; Groppetti et al., 1969; Traylor
and Breese, 1970). TJretsky and Iversen (1969)
have found brain norepinephrine to be lowered
for as long as 32 days, thus lending strong
support to the view that noradrenergic de
generation could be induced by 6-hydroxy
dopamine. The present study shows that
depletion of brain catecholamines persists at 78
days. With the use of electron microscopy,
Bloom and co-workers (1969) have confirmed
the presence of degenerating norepinephrine
neurons within the central nervous system after
administering 6-hydroxydopamine intracister
nally. Several reports have indicated that sym
pathetic denervation decreases tyrosine hydrox
ylase activity in peripheral organs with
adrenergic innervation (Sedvall et al., 1967;
Mueller et al., 1969). Therefore, the marked
reduction of tyrosine hydroxylase activity in
brain (table 2) and the decreased noreinephrine
synthesis from tyrosine (table 1) after 6-hy
droxydopamine treatment not only add support
to the view that noradrenergic neuronal degen
eration occurs but also suggests that destruction
is quite widespread.
Bloom and associates (1969) recently reported
that norepinephrine neurons were more sensi
tive to depletion by 6-hydroxydopamine than
dopaminergic nerve cells. The results of this
present study are in full agreement with these
earlier results (fig. 3). This observation might
have been expected because of the report that
dopaminergic neurons are resistant to depletion
by intracisternally administered amphetamine
derivatives which lower brain norepinephrine
levels significantly (Breese et at., 1970). Pre
liminary evidence indicates that a multiple in
jection sequence of lower doses of 6-hydroxy
dopamine may deplete norepinephrine to an
even greater extent than a single injection with
minimal influence on brain dopamine levels (un
published data).
The study of the effects of 6-hydroxydopamine
peripherally indicated that selective degenera
tion of adrenergic nerves occurred only in the
distal part of the neuron, but not in the pen
karyon (Tranzer and Thoenen, 1968). In brain,
Bloom and associates (1969) found depletion of
nonepinephnine by 6-hydroxydopamine to be
greatest in areas containing axons and nerve
terminals and least in those areas which con
tamed biogenic amine cell bodies. Whereas elec
tron microscopic evaluation of fiber endings
would strongly suggest that 6-hydroxydopamine
eliminates norepinephrine-containing terminals,
the morphologic evidence concerning the fate of
the cell bodies is not yet available (Bloom et at.,
1969). In the present study, all brain areas seem
to be influenced uniformly by the neunonal tox
icity of 6-hydroxydopamine. Whether this in
creased effect may be due to adrenergic ccli body
destruction or to an increased effectiveness on
fiber terminals was not established. Whatever
may be the case, it is clear that the effects are
quite prolonged (fig. 2), suggesting that axonal
regeneration does not occur within the central
nervous system as previously reported for the
periphery (Thoenen and Tranzer, 1968).
After the monoamine oxidase inhibitor par
gyline, 6-hydroxydoparnine (200 @tg)was found
to decrease not only brain norepinephrine but
also dopamine (fig. 1). Early observations in
our laboratoryhad indicatedthatbraindopa
mine was only moderately altered by 6-hydroxy
dopamine. With this in mind, it was reasoned
that taking advantage of the fact that amines
pass slowly from the central nervous system af
ter monoamine oxidase inhibition (Schanberg,
et ci., 1968; Breese et al., 1969) this minor ef
fect of 6-hydroxydopamine could be amplified.
As shown in figure 1, this procedure has per
mitted consistent depletion of brain dopamine
as well as norepinephrine (Breese et at., 1970).
Furthermore, the results of the present study
and the recent work of Uretsky and Iversen
(1970) emphasize that dopaminergic neurons are
not only depleted but are probably affected by
the neurotoxicity of 6-hydroxydopamine. This
is exemplified by the prolonged depletion of
dopamine (fig. 2), by lack of in vivo synthesis -
of labeled dopamine from W-tyrosine (table 1)
and by the reduction of tyrosine hydroxylase
activity in the basal ganglia, (table 2) well
known for its high dopamine content (Canlsson,
1959). In further support of this view, F. E.
Bloom (personal communication) has recently
found degenerating fibers in the caudate of
pargyline-treated animals which have received
6-hydroxydopamine intracisternally.
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vine in the hearts of mice. J. Pharmacol. Exp.
Ther. 140: 308â€”316,1963.
SCHANBERG, S. M., ScHIU.Ltrr, J. J., BREESE,
G. R. ANDKopm@,I. J.: Metabolism of normeta
nephrine in rat brain: Identification of conju
gated 3-methoxy-4-hydroxyphenylglycol as the
After the administration of BY-norepineph
rine the amount of labeled normetanephrine iso
lated from brains of 6-hydroxydopamine
treated animals was increased considerably over
levels in control brains. This suggests that the
enzyme catechol-O-methyltransferase is not al
tered by 6-hydroxydopamine treatment. The
reduction of deaminated catechols and the in
creased amounts of normetanephrine observed
after 6-hydroxydopamine treatment is similar
to but greater than that reported to occur after
desipramine (Schanberg et ci., 1967; Schild
kraut et at., 1967). These results are probably
linked to the decreased neuronal uptake ob
served to occur after both desipramine and 6-
hydroxydopamine (Schanberg et at., 1967, fig.
2).
Selective elimination of central norepineph
rine or norepinephrine and dopamine neurons
should aid significantly in the effort to define
the central role of these amines. However, the
usefulness of 6-hydroxydopamine as a pharma
cologic agent for evaluating the central role of
catecholamines has yet to be established. In
view of the central function attributed to these
amines, it has been somewhat surprising to find
that the general appearance of rats â€œ¿centrally
sympathectomizedâ€• with 6-hydroxydopamine
has thus far been grossly indistinguishable from
that of untreated controls except for a slight
decreasein body weight and a lack of self
grooming. Certainly these animals do not dis
play a classical â€œ¿reserpinesyndromeâ€•(Bein,
1953). Experiments are presently underway to
evaluate further the role of 6-hydroxydopamine
as a specific tool for the study of central adre
nergic mechanisms.
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